- Home
- Publications
- Publication Search
- Publication Details
Title
Formulation Considerations for the Management of Dry Eye Disease
Authors
Keywords
-
Journal
Pharmaceutics
Volume 13, Issue 2, Pages 207
Publisher
MDPI AG
Online
2021-02-04
DOI
10.3390/pharmaceutics13020207
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Developing evidence-based guidance for the treatment of dry eye disease with artificial tear supplements: A six-month multicentre, double-masked randomised controlled trial
- (2021) Jennifer P. Craig et al. Ocular Surface
- Polymeric Nanoparticles for Drug Delivery: Recent Developments and Future Prospects
- (2020) Belén Begines et al. Nanomaterials
- Prophylactic action of lipid and non-lipid tear supplements in adverse environmental conditions: A randomised crossover trial
- (2020) Alex Muntz et al. Ocular Surface
- Ocular Pharmacokinetics of a Topical Ophthalmic Nanomicellar Solution of Cyclosporine (Cequa®) for Dry Eye Disease
- (2019) Abhirup Mandal et al. PHARMACEUTICAL RESEARCH
- A Clinical Phase II Study to Assess Efficacy, Safety, and Tolerability of CyclASol for Treatment of Dry Eye Disease
- (2019) David L. Wirta et al. OPHTHALMOLOGY
- Preclinical studies evaluating the effect of semifluorinated alkanes on ocular surface and tear fluid dynamics
- (2019) Priyanka Agarwal et al. Ocular Surface
- Topical semifluorinated alkane-based azithromycin suspension for the management of ocular infections
- (2019) Priyanka Agarwal et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Semifluorinated alkane based systems for enhanced corneal penetration of poorly soluble drugs
- (2018) Priyanka Agarwal et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Tear lipid supplement prophylaxis against dry eye in adverse environments
- (2018) Akilesh Gokul et al. Contact Lens & Anterior Eye
- Can the optimum artificial tear treatment for dry eye disease be predicted from presenting signs and symptoms?
- (2018) Laika Essa et al. Contact Lens & Anterior Eye
- Novel liposome-based and in situ gelling artificial tear formulation for dry eye disease treatment
- (2018) Duygu Acar et al. Contact Lens & Anterior Eye
- Cyclosporine A delivery to the eye: A comprehensive review of academic and industrial efforts
- (2017) Frédéric Lallemand et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Novel anti-inflammatory liposomal formulation for the pre-ocular tear film: In vitro and ex vivo functionality studies in corneal epithelial cells
- (2017) Laura Soriano-Romaní et al. EXPERIMENTAL EYE RESEARCH
- Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease Due to Meibomian Gland Disease
- (2017) Philipp Steven et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- TFOS DEWS II iatrogenic report
- (2017) José Alvaro P. Gomes et al. Ocular Surface
- TFOS DEWS II pathophysiology report
- (2017) Anthony J. Bron et al. Ocular Surface
- TFOS DEWS II Epidemiology Report
- (2017) Fiona Stapleton et al. Ocular Surface
- TFOS DEWS II Management and Therapy Report
- (2017) Lyndon Jones et al. Ocular Surface
- TFOS DEWS II Definition and Classification Report
- (2017) Jennifer P. Craig et al. Ocular Surface
- Effect of lipid-based dry eye supplements on the tear film in wearers of eye cosmetics
- (2017) Michael T.M. Wang et al. Contact Lens & Anterior Eye
- Potential Use of Cyclodextrin Complexes for Enhanced Stability, Anti-inflammatory Efficacy, and Ocular Bioavailability of Loteprednol Etabonate
- (2016) Osama Abd El-Aazeem Soliman et al. AAPS PHARMSCITECH
- Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction
- (2016) Christophe Baudouin et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Functional impairment of reading in patients with dry eye
- (2016) Priya M Mathews et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Mechanisms of Visual Disturbance in Dry Eye
- (2016) Shizuka Koh CORNEA
- Modern approaches to the ocular delivery of cyclosporine A
- (2016) Priyanka Agarwal et al. DRUG DISCOVERY TODAY
- Preformulation Studies of a Liposomal Formulation Containing Sirolimus for the Treatment of Dry Eye Disease
- (2016) Mónica Anayántzin Linares-Alba et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Comparing self-reported optometric dry eye clinical practices in Australia and the United Kingdom: is there scope for practice improvement?
- (2016) Laura E. Downie et al. OPHTHALMIC AND PHYSIOLOGICAL OPTICS
- The effect of trehalose 3% as adjuvant therapy on Lasik procedure
- (2015) A.J. Mateo Orobia et al. ACTA OPHTHALMOLOGICA
- Critical appraisal of alternative irritation models: three decades of testing ophthalmic pharmaceuticals
- (2015) H. Abdelkader et al. BRITISH MEDICAL BULLETIN
- Efficacy, Safety, and Acceptability of a Lipid-Based Artificial Tear Formulation: A Randomized, Controlled, Multicenter Clinical Trial
- (2015) Peter A. Simmons et al. CLINICAL THERAPEUTICS
- Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease—A Prospective, Multicenter Noninterventional Study
- (2015) Philipp Steven et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- The Presence and Significance of Polar Meibum and Tear Lipids
- (2015) Andrew D. Pucker et al. Ocular Surface
- Isotonic Glycerol and Sodium Hyaluronate Containing Artificial Tear Decreases Conjunctivochalasis after One and Three Months: A Self-Controlled, Unmasked Study
- (2015) Huba J. Kiss et al. PLoS One
- Topical Ocular Drug Delivery to the Back of the Eye by Mucus-Penetrating Particles
- (2015) Lisa R. Schopf et al. Translational Vision Science & Technology
- Influence of different surfactants on the technological properties and in vivo ocular tolerability of lipid nanoparticles
- (2014) Antonio Leonardi et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Phenylboronic acid modified mucoadhesive nanoparticle drug carriers facilitate weekly treatment of experimentallyinduced dry eye syndrome
- (2014) Shengyan Liu et al. Nano Research
- Nanoparticle diffusion in respiratory mucus from humans without lung disease
- (2013) Benjamin S. Schuster et al. BIOMATERIALS
- Effectiveness of Dry Eye Therapy Under Conditions of Environmental Stress
- (2013) Alan Tomlinson et al. CURRENT EYE RESEARCH
- Developing an in situ nanosuspension: A novel approach towards the efficient administration of poorly soluble drugs at the anterior eye
- (2013) Christoph Luschmann et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Role of Hyperosmolarity in the Pathogenesis and Management of Dry Eye Disease: Proceedings of the OCEAN Group Meeting
- (2013) Christophe Baudouin et al. Ocular Surface
- Mucus Penetrating Nanoparticles: Biophysical Tool and Method of Drug and Gene Delivery
- (2012) Laura M. Ensign et al. ADVANCED MATERIALS
- Distribution of Cyclosporine A in Ocular Tissues After Topical Administration of Cyclosporine A Cationic Emulsions to Pigmented Rabbits
- (2012) Philippe Daull et al. CORNEA
- Azithromycin 1.5% Ophthalmic Solution
- (2012) Karly P. Garnock-Jones DRUGS
- Novel micelle carriers for cyclosporin A topical ocular delivery: In vivo cornea penetration, ocular distribution and efficacy studies
- (2012) Claudia Di Tommaso et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Predicted Phenotypes of Dry Eye: Proposed Consequences of Its Natural History
- (2012) Anthony J. Bron et al. Ocular Surface
- A Comparison of an Eyelid-Warming Device to Traditional Compress Therapy
- (2012) Heiko Pult et al. OPTOMETRY AND VISION SCIENCE
- Controlled and Continuous Release Ocular Drug Delivery Systems: Pros and Cons
- (2012) Hamdy Abdelkader et al. Current Drug Delivery
- Low molecular weight chitosan-coated liposomes for ocular drug delivery:In vitroandin vivostudies
- (2011) Ning Li et al. DRUG DELIVERY
- Demonstration of Efficacy in the Treatment of Dry Eye Disease with 0.18% Sodium Hyaluronate Ophthalmic Solution (Vismed, Rejena)
- (2010) Roger Vogel et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Effects of a New Lipid Tear Substitute in a Mouse Model of Dry Eye
- (2010) Christian Scifo et al. CORNEA
- Efficacy of Hydroxypropyl Cellulose Ophthalmic Inserts (LACRISERT) in Subsets of Patients With Dry Eye Syndrome: Findings From a Patient Registry
- (2010) Jodi I Luchs et al. CORNEA
- The Economic Burden of Dry Eye Disease in the United States: A Decision Tree Analysis
- (2010) Junhua Yu et al. CORNEA
- Improved Signs, Symptoms, and Quality of Life Associated With Dry Eye Syndrome: Hydroxypropyl Cellulose Ophthalmic Insert Patient Registry
- (2010) Bruce H. Koffler et al. Eye & Contact Lens-Science and Clinical Practice
- Preservatives in eyedrops: The good, the bad and the ugly
- (2010) Christophe Baudouin et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Effect of a liposomal spray on the pre-ocular tear film
- (2010) Jennifer P. Craig et al. Contact Lens & Anterior Eye
- Cyclosporine A-Loaded Solid Lipid Nanoparticles: Ocular Tolerance andIn VivoDrug Release in Rabbit Eyes
- (2009) Evren H. Gökçe et al. CURRENT EYE RESEARCH
- Self-assembled cyclodextrin aggregates and nanoparticles
- (2009) Martin Messner et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Prevalence of Ocular Surface Disease in Glaucoma Patients
- (2009) Eamon W. Leung et al. JOURNAL OF GLAUCOMA
- Barriers to Glaucoma Drug Delivery
- (2009) Deepta Ghate et al. JOURNAL OF GLAUCOMA
- Comparative Toxicity of Preservatives on Immortalized Corneal and Conjunctival Epithelial Cells
- (2009) Seth P. Epstein et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
- (2008) Samuel K. Lai et al. ADVANCED DRUG DELIVERY REVIEWS
- A cleaning solution for silicone intraocular lenses: "sticky silicone oil"
- (2008) Y Liang et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Effect of Hypotonic 0.4% Hyaluronic Acid Drops in Dry Eye Patients: A Cross-Over Study
- (2008) Pasquale Troiano et al. CORNEA
- Ocular nanoparticle toxicity and transfection of the retina and retinal pigment epithelium
- (2008) Tarl W. Prow et al. Nanomedicine-Nanotechnology Biology and Medicine
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started